Tuesday, November 29, 2016 2:53:36 PM
So they get $15million now and up to 140million for a compound they weren't going to pursue. Nicely done IMO. Ho hum for the market but very nice for the balance sheet. Add in the recent financingat $2 and IDRA is well funded through 2017 if they maintain their average 2016 quarterly burn rate of $13million. For now I think that $2 financing is the biggest part of the price ceiling.
All IMO only.
IDRA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM